CellSeed's Regenerative medicine technology
CellSeed continue to focus our efforts on commercializing cell sheet regenerative medicine to bring these products to market.
- Others Company Brochure – Fiscal Year 2021, “With You CellSeed Vol. 14”
- Others Bridge Report the fiscal year 2021
- IR Summary of Non-Consolidated Financial Results for the Three Months Ended March 31, 2022 (J-GAAP)
- IR Fiscal 2021 Earnings Results Presentation
- IR Summary of Consolidated Financial Results for the Year Ended December 31, 2021 (J-GAAP)